- Home
- RSVR vs TMCI Comparison
RSVR vs TMCI Comparison
Compare RSVR & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RSVR | TMCI |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.2M | 401.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | RSVR | TMCI |
|---|---|---|
| Price | $7.53 | $2.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $11.50 | $7.07 |
| AVG Volume (30 Days) | 68.7K | ★ 1.2M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $166,320,844.00 | ★ $218,879,000.00 |
| Revenue This Year | $7.17 | $10.63 |
| Revenue Next Year | $5.00 | $9.43 |
| P/E Ratio | $51.80 | ★ N/A |
| Revenue Growth | ★ 11.17 | 7.90 |
| 52 Week Low | $6.56 | $2.56 |
| 52 Week High | $9.83 | $10.79 |
Technical Indicators
Market Signals| Indicator | RSVR | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 24.74 |
| Support Level | $7.19 | $2.56 |
| Resistance Level | $7.49 | $3.15 |
| Average True Range (ATR) | 0.19 | 0.32 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 77.89 | 19.92 |
Price Performance
Historical ComparisonAbout RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. It operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the Music Publishing segment.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.